Top Markets
#1 Ontology Ontology +44.87%
#2 Bedrock Bedrock +24.56%
#3 Naoris Protocol Naoris Protocol +20.60%
#4 TARS AI TARS AI +20.15%
#5 bitcastle Token bitcastle Token +20.01%
#6 DeFiChain DeFiChain +19.51%
#7 ETHGas ETHGas +19.47%
#8 pippin pippin +19.32%
#9 Chrema Coin Chrema Coin +15.54%
#10 DUSK Network DUSK Network +15.52%
Coin of the day
Ontology Ontology
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Eli Lilly Eli Lilly

Eli Lilly

LLY
Kedudukan dalam Saham #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Harga Saham
$910.55
Modal Pasaran
$860.30B
Perubahan (1 hari)
0.44%
Perubahan (1 tahun)
5.28%
Negara
US
Perdagangan Eli Lilly (LLY)

Kategori

Healthcare
Bilangan saham terbitan bagi Eli Lilly (LLY)
Bilangan saham terbitan setakat December 2025: 898.00M
Menurut laporan kewangan terkini dan harga saham Eli Lilly, bilangan saham terbitan semasa ialah 898.00M. Pada akhir December 2024, syarikat mempunyai 900.61M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Eli Lilly (LLY) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 898.00M 0.00%
2025 898.00M -0.29%
2024 900.61M 0.14%
2023 899.38M -5.35%
2022 950.18M -0.36%
2021 953.65M -0.31%
2020 956.59M -0.10%
2019 957.53M -6.83%
2018 1.03B -2.31%
2017 1.05B -4.44%
2016 1.10B -0.40%
2015 1.11B -0.48%
2014 1.11B -0.55%
2013 1.12B -2.59%
2012 1.15B 2.92%
2011 1.11B 0.74%
2010 1.11B 0.68%
2009 1.10B 0.35%
2008 1.09B 0.37%
2007 1.09B 0.33%
2006 1.09B -0.08%
2005 1.09B 0.35%
2004 1.08B 0.74%
2003 1.08B -0.27%
2002 1.08B 0.12%
2001 1.08B -0.28%
2000 1.08B 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 245.21%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.43B 170.44%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.78B 98.26%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B 113.03%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 2.49B 177.27%
US